EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells.

Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins and thromboxanes from free arachidonic acid. Increasing evidence suggests that COX-2 plays a role in tumorigenesis. A variety of stimuli induce COX-2 and it is overexpressed in many tumors, including non-small cell lung cancer (NSCLC). We studied the regulation of COX-2 expression in immortalized human bronchial epithelial cells (HBECs) by transforming growth factor-beta1 (TGF-beta1) and epidermal growth factor (EGF) because these two growth factors are present in both the pulmonary milieu of those at risk for lung cancer as well as in the tumor microenvironment. EGF significantly enhanced TGF-beta1-mediated induction of COX-2 and corresponding prostaglandin E2 (PGE2) production. TGF-beta1 and EGF induced COX-2 at the transcriptional and post-transcriptional levels. EGF receptor (EGFR) inhibition, neutralizing antibody against amphiregulin, or mitogen-activated protein kinase kinase (MEK) inhibition blocked TGF-beta1-mediated COX-2 induction. COX-2 induction by TGF-beta1 depended upon Smad3 signaling and required the activity of EGFR or its downstream mediators. Autocrine amphiregulin signaling maintains EGFR in a constitutively active state in HBECs, allowing for COX-2 induction by TGF-beta1. Thus, EGFR ligands, which are abundant in the pulmonary microenvironment of those at risk for lung cancer, potentiate and are required for COX-2 induction by TGF-beta1 in HBEC. These findings emphasize the central role of EGFR signaling in COX-2 induction by TGF-beta1 and suggest that inhibition of EGFR signaling should be investigated further for lung cancer prevention.

[1]  P. Loehrer.  Celecoxib for the Prevention of Colorectal Adenomatous Polyps , 2008 .

[2]  S. Solomon,et al.  Celecoxib for the prevention of sporadic colorectal adenomas. , 2006, The New England journal of medicine.

[3]  John Mendelsohn,et al.  Epidermal growth factor receptor targeting in cancer. , 2006, Seminars in oncology.

[4]  David C. Lee,et al.  Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. , 2006, Cancer research.

[5]  Robert M Elashoff,et al.  A Phase I Trial to Determine the Optimal Biological Dose of Celecoxib when Combined with Erlotinib in Advanced Non–Small Cell Lung Cancer , 2006, Clinical Cancer Research.

[6]  R. Cameron,et al.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.

[7]  P. Hiemstra,et al.  Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. , 2006, American journal of clinical pathology.

[8]  D. Elashoff,et al.  Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[9]  T. Kinoshita,et al.  Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. , 2005, Biochemical and biophysical research communications.

[10]  J. Minna,et al.  EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. , 2005, Cancer research.

[11]  S. Prime,et al.  Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF‐β1 involves MAPK, Smad and AP‐1 signalling pathways , 2005, Journal of cellular biochemistry.

[12]  S. Poulsen,et al.  Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. , 2005, Molecular human reproduction.

[13]  R. Strieter,et al.  Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. , 2005, Clinical lung cancer.

[14]  S. Leivonen,et al.  Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. , 2005, The Journal of investigative dermatology.

[15]  Gerard C Blobe,et al.  Role of transforming growth factor Beta in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Y. Wen,et al.  [The effects of bilirubin concentration on laminin and epidermal growth factor expression in lung tissue and type II pneumocytes in smoking rats model]. , 2005, Zhonghua nei ke za zhi.

[17]  N. Altorki,et al.  Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. , 2005, Cancer research.

[18]  E. Rozengurt,et al.  Angiotensin II and Epidermal Growth Factor Induce Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Small GTPases Using Distinct Signaling Pathways* , 2005, Journal of Biological Chemistry.

[19]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[20]  B. Rovin,et al.  Epidermal Growth Factor and Interleukin-1β Utilize Divergent Signaling Pathways to Synergistically Upregulate Cyclooxygenase-2 Gene Expression in Human Amnion-Derived WISH Cells1 , 2004, Biology of reproduction.

[21]  K. Creek,et al.  RNA degradation in human breast tissue after surgical removal: a time-course study. , 2004, Experimental and molecular pathology.

[22]  Y. Surh,et al.  Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. , 2004, Biochemical pharmacology.

[23]  P. Kvale,et al.  Cancer and interstitial lung disease , 2004, Current opinion in pulmonary medicine.

[24]  Kyoung-Chan Park,et al.  Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. , 2004, The international journal of biochemistry & cell biology.

[25]  R. Strieter,et al.  Multifaceted roles of cyclooxygenase-2 in lung cancer. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[26]  L. Salford,et al.  Identification and characterization of a human smad3 splicing variant lacking part of the linker region. , 2004, Gene.

[27]  M. Burdick,et al.  Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer , 2004, Cancer Research.

[28]  E. Rowinsky.  The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. , 2004, Annual review of medicine.

[29]  D. Seligson,et al.  COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  Edward S. Kim,et al.  Chemoprevention of lung cancer , 2004, Journal of the Medical Association of Georgia.

[31]  M. Roth,et al.  Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  L. Lanting,et al.  Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products* , 2003, Journal of Biological Chemistry.

[33]  L. Slice,et al.  Gastrin and EGF synergistically induce cyclooxygenase‐2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor , 2003, Journal of cellular physiology.

[34]  H. Schnaper,et al.  Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. Levitzki.  EGF receptor as a therapeutic target. , 2003, Lung cancer.

[36]  S. Kambhampati,et al.  p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion , 2003, Oncogene.

[37]  H. Reber,et al.  PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. , 2003, Biochemical and biophysical research communications.

[38]  Lesley Seymour,et al.  Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. , 2003, The Lancet. Oncology.

[39]  M. Huang,et al.  Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  Li Zhu,et al.  Abnormal Interleukin 10Rα Expression Contributes to the Maintenance of Elevated Cyclooxygenase-2 in Non-Small Cell Lung Cancer Cells , 2003 .

[41]  M. Dohadwala,et al.  Cyclooxygenase-2 in lung cancer. , 2003, Progress in experimental tumor research.

[42]  Li Zhu,et al.  Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. , 2003, Cancer research.

[43]  H. Reber,et al.  PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. , 2003, Biochemical and biophysical research communications.

[44]  M. Dohadwala,et al.  Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion* , 2002, The Journal of Biological Chemistry.

[45]  R. Akhurst.  TGF-β antagonists: Why suppress a tumor suppressor? , 2002 .

[46]  J. Morrow,et al.  Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-β1 in immortalized mouse colonocytes expressing oncogenic ras , 2002, Journal of Gastrointestinal Surgery.

[47]  M. Dohadwala,et al.  Microarray identifies cyclo-oxygenase-2-dependent modulation of insulin-like growth factor binding protein-3 in non-small cell lung cancer cells. , 2002, Chest.

[48]  R. Akhurst.  TGF-beta antagonists: why suppress a tumor suppressor? , 2002, The Journal of clinical investigation.

[49]  E. Dmitrovsky,et al.  Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  L. Attisano,et al.  Cross-talk between the p42/p44 MAP Kinase and Smad Pathways in Transforming Growth Factor β1-induced Furin Gene Transactivation* , 2001, The Journal of Biological Chemistry.

[51]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[52]  Li Zhu,et al.  Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44* , 2001, The Journal of Biological Chemistry.

[53]  F. Yamasawa,et al.  Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). , 2001, American journal of respiratory and critical care medicine.

[54]  A. Balmain,et al.  TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.

[55]  R. Beauchamp,et al.  TGF-beta and colorectal carcinogenesis. , 2001, Microscopy research and technique.

[56]  B. Fanburg,et al.  Transforming Growth Factor-β1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor , 2000 .

[57]  S. Belinsky,et al.  Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. , 2000, Carcinogenesis.

[58]  D. Dixon,et al.  Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA* , 2000, The Journal of Biological Chemistry.

[59]  B. Fanburg,et al.  Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. , 2000, The Journal of biological chemistry.

[60]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[61]  J. Morrow,et al.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. , 1999, Neoplasia.

[62]  K. Subbaramaiah,et al.  Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells , 1999, The Journal of Biological Chemistry.

[63]  K. Subbaramaiah,et al.  Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. , 1999, The Journal of biological chemistry.

[64]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[65]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[66]  S. Jimenez,et al.  Differential Regulation of Cyclooxygenases 1 and 2 by Interleukin-1β, Tumor Necrosis Factor-α, and Transforming Growth Factor-β1 in Human Lung Fibroblasts , 1998 .

[67]  Li Zhu,et al.  Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. , 1998, Cancer research.

[68]  C. Angeletti,et al.  Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  S. Jimenez,et al.  Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. , 1998, Experimental cell research.

[70]  R. Weinberg,et al.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Drazen,et al.  Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. , 1997, The Journal of clinical investigation.

[72]  G. Plowman,et al.  Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549. , 1992, Growth factors.

[73]  M. Sporn,et al.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. , 1990, Science.